Effects of chronic thyroid hormone administration on pregnancy, lactogenesis and lactation in the rat.
We studied the effects of daily administration of 1 mg/kg thyroxine (T4) starting 10-15 days before mating, on parturition, maternal behavior and lactation in rats. Treated rats had elevated serum titers of T3 and T4, a greater number of fetuses and parturition was advanced approximately 12 h and lasted longer than in controls. None of the treated rats were able to lactate because of defects in maternal behavior and milk ejection; the litters died usually within 48 h postpartum. In rats sacrificed at 10.00 on day 21 of pregnancy, mammary gland content of total protein, phospholipids, casein and lactose were significantly increased, but total lipid was markedly reduced. Lipogenesis was also significantly increased, as well as the activity of the lipogenic enzymes glucose-6-phosphate dehydrogenase, fatty acid synthetase and isocitrate dehydrogenase. These results are indicative of normal albeit premature lactogenesis. The T4-treated rats also had advances in the prepartum fall in serum progesterone and the increase in prolactin as well as in the increase in mammary casein and lactose concentrations of approximately 12 h with respect to control pregnant rats. These results show that chronic T4 treatment induces an advance of approximately 12 h in luteolysis, which in turn advances lactogenesis and parturition in rats. Although the mammary gland was able to produce milk, lactation failed due to abnormal maternal behavior and milk ejection, the causes of which are still unknown. Other effects of hyperthyroidism were also present, such as a severe reduction in lipid content of the gland.(ABSTRACT TRUNCATED AT 250 WORDS)
Rosato
R R
RR
Catedra de Quimica Biologica II, Facultad de Quimica, Bioquimica y Farmacia, Universidad Nacional de San Luis, Argentina.
Gimenez
M S
MS
Jahn
G A
GA
D000818:Animals; D001723:Birth Rate; D001835:Body Weight / Q000187:drug effects; D002364:Caseins / Q000032:analysis / Q000378:metabolism; D064429:Fatty Acid Synthases / Q000032:analysis; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D007521:Isocitrate Dehydrogenase / Q000032:analysis; D007743:Labor, Obstetric / Q000187:drug effects / Q000502:physiology; D007774:Lactation / Q000187:drug effects* / Q000502:physiology; D007785:Lactose / Q000032:analysis / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000737:chemistry / Q000378:metabolism / Q000502:physiology; D008425:Maternal Behavior; D008893:Milk Ejection / Q000187:drug effects* / Q000502:physiology; D010743:Phospholipids / Q000032:analysis / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D011374:Progesterone / Q000097:blood; D011388:Prolactin / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D012726:Sexual Behavior, Animal / Q000187:drug effects / Q000502:physiology; D013974:Thyroxine / Q000097:blood / Q000494:pharmacology*; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
D002364:Caseins; D010743:Phospholipids; D014284:Triiodothyronine; D011374:Progesterone; D011388:Prolactin; D007521:Isocitrate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D064429:Fatty Acid Synthases; D007785:Lactose; D013974:Thyroxine